Gilead has announced that lenacapavir, the game-changing HIV prevention drug just approved by the FDA will cost $28,218 USD per person per year.
Researchers say a generic version could be made for just $25 per person a year.
Capitalism kills.
Gilead has announced that lenacapavir, the game-changing HIV prevention drug just approved by the FDA will cost $28,218 USD per person per year.
Researchers say a generic version could be made for just $25 per person a year.
Capitalism kills.
@luckytran In a hypothetical world without those greedy bastards at Gilead, though, we don't get lenacapavir at $25/year, we get no lenacapavir at all. (Because lenacapavir was discovered by Gilead. They were willing to put in the effort and resources because they hoped it would lead them to a drug that they could make a lot of money from.)
In a more distant hypothetical world without capitalism, _maybe_ we get all the same drug discovery that in our rotten greedy capitalist world is done by companies who hope it will make them rich, and then the drugs get made available at non-extortionate prices. That would be nice. But how do you know that's what we'd get?